Thrombocytosis

What is thrombocytosis?

Platelets are the cells responsible for patching up wounds and stopping bleeding. You need enough of them circulating to respond quickly when needed, but too many can start to cause problems of their own.

A normal platelet count sits between 150 and 400. Once it passes 450, it's called thrombocytosis, and at this point there are enough platelets circulating that clotting risk starts to rise. There are two main reasons this happens:

• The body’s reaction (reactive thrombocytosis): The most common cause. The bone marrow itself is healthy, but it's overproducing platelets in response to something else, like an infection, an injury, or low iron. Treat that underlying problem, and the platelet count usually returns to normal.

• The source problem (primary thrombocytosis): This is rarer and more serious. It means the bone marrow itself is malfunctioning and producing platelets uncontrollably. This needs specialist care, since the risk of dangerous blood clots or strokes is much higher.

Symptoms of thrombocytosis

Many people with thrombocytosis have no symptoms, especially in reactive cases. When symptoms do occur, most commonly in primary forms, they include:

• Neurological: persistent headaches, dizziness, or visual disturbances.

• Vascular: burning or tingling in the hands and feet (erythromelalgia).

• Clotting risks: increased likelihood of stroke, TIA, or deep vein thrombosis.

• Paradoxical bleeding: ironically, very high counts can impair clotting, leading to bruising or nosebleeds.

• Organ changes: an enlarged spleen, often seen in bone marrow disorders.

While reactive thrombocytosis usually only shows signs of the underlying infection or injury, primary cases require careful monitoring to prevent serious vascular events.

What causes thrombocytosis?

Causes depend on whether the condition is reactive (a response to external factors) or primary (a bone marrow issue).

Reactive thrombocytosis:

• Iron deficiency anaemia: the most common cause, as the body ramps up platelet production to compensate for low iron.

• Infection and inflammation: conditions like arthritis or bowel disease trigger platelet release through inflammatory signals.

• Surgery or Injury: counts often peak shortly after major surgery or tissue damage as the body heals.

• Spleen removal: losing the spleen removes the primary site where platelets are cleared from the blood.

• Malignancy: certain tumors produce cytokines that drive high platelet counts.

• Vitamin deficiency: folate and B12 deficiency correction can temporarily elevate platelet count as bone marrow rebounds

Primary thrombocytosis:

• Essential thrombocythaemia (ET): a clonal myeloproliferative neoplasm; frequently associated with JAK2 V617F mutation (present in ~50–60% of ET cases) or CALR/MPL mutations

• Polycythaemia vera: elevated red cells with associated thrombocytosis

• Myelofibrosis: bone marrow scarring with abnormal platelet production

Thrombocytosis is detected directly through blood testing, with further investigation guided by the platelet count level and clinical context.

Blood tests Elfcare's panel includes platelet count as part of the full blood count, alongside markers that help distinguish reactive from primary forms:

• Platelet count: the primary marker. Counts above 450 confirm thrombocytosis; levels over 1,000 strongly suggest a bone marrow disorder.

• Full blood count (FBC): evaluates red and white cells; abnormalities across multiple cell types often point toward primary marrow issues.

• Iron panel (ferritin, iron, saturation): identifies iron deficiency, the most common cause of reactive (temporary) high platelets.

• CRP and ESR: high inflammation markers suggest the platelet rise is a reactive response to an infection or inflammatory condition.

• B12 and folate: deficiencies in these vitamins can disrupt platelet production and are used to rule out nutritional causes.

• Liver function (ALT, AST, ALP): assesses for hepatic involvement, which can occur in certain bone marrow diseases.

• LDH: a marker of cell turnover; elevated levels can signal haematological malignancies or bone marrow disorders.

• Uric acid: high levels often reflect the increased cell turnover associated with primary bone marrow conditions.

Why early detection matters

Reactive thrombocytosis is important to identify because it almost always signals an underlying condition, most commonly iron deficiency, that requires treatment in its own right. Primary thrombocytosis, particularly essential thrombocythaemia, carries a significant risk of life-threatening thrombotic events including stroke, heart attack, and pulmonary embolism, as well as transformation to myelofibrosis or acute leukaemia over time. Early identification allows for risk stratification, antiplatelet therapy, and cytoreductive treatment in high-risk patients, all of which substantially reduce the risk of these outcomes.

How Elfcare can help

Elfcare's full blood count includes platelet count as standard, making thrombocytosis a directly detectable finding in every health check. Our panel also covers ferritin, iron markers, CRP, B12, folate, and liver function, providing the context needed to distinguish the most common reactive causes from findings that require specialist haematological assessment.

If our blood tests identify an elevated platelet count or related findings, we take care of further diagnostics or refer you to the appropriate specialist.